02257.HK
Sirnaomics Ltd.
HKSE · Healthcare · Biotechnology · HK
HKD 4.13
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
175.4%
Return on equity
-79.3%
Return on assets
-72.7%
Return on invested capital
0.00x
Asset turnover
-HKD 71.4M
Cash from operations
HKD 0.60
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026